Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.90−0.10 (-3.33%)
Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –
Nephros revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nephros's revenue for the twelve months ending Jun 30, 2026 was $20.72M, up 24.2% year over year. For fiscal 2025 it was $18.79M, up 32.7% from the year before. Over ten years it grew 25.5% a year on average. The highest annual figure on record is $18.79M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.79M | +32.7% |
| FY2024 | Dec 31, 2024 | $14.16M | -0.5% |
| FY2023 | Dec 31, 2023 | $14.24M | +42.7% |
| FY2022 | Dec 31, 2022 | $9.98M | -2.4% |
| FY2021 | Dec 31, 2021 | $10.22M | +19.3% |
| FY2020 | Dec 31, 2020 | $8.56M | -17.2% |
| FY2019 | Dec 31, 2019 | $10.33M | +81.7% |
| FY2018 | Dec 31, 2018 | $5.69M | +49.3% |
| FY2017 | Dec 31, 2017 | $3.81M | +64.2% |
| FY2016 | Dec 31, 2016 | $2.32M | +19.3% |
| FY2015 | Dec 31, 2015 | $1.94M | +11.2% |
| FY2014 | Dec 31, 2014 | $1.75M | +0.5% |
| FY2013 | Dec 31, 2013 | $1.74M | -3.7% |
| FY2012 | Dec 31, 2012 | $1.81M | -18.4% |
| FY2011 | Dec 31, 2011 | $2.21M | -24.6% |
| FY2010 | Dec 31, 2010 | $2.94M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.02M | +36.2% |
| Q1 FY2026 | Mar 31, 2026 | $5.21M | +6.9% |
| Q4 FY2025 | Dec 31, 2025 | $4.73M | +22.2% |
| Q3 FY2025 | Sep 30, 2025 | $4.76M | +35.4% |
| Q2 FY2025 | Jun 30, 2025 | $4.42M | +35.9% |
| Q1 FY2025 | Mar 31, 2025 | $4.88M | +38.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.87M | +18.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.52M | -6.0% |
| Q2 FY2024 | Jun 30, 2024 | $3.25M | -8.3% |
| Q1 FY2024 | Mar 31, 2024 | $3.52M | -4.7% |
| Q4 FY2023 | Dec 31, 2023 | $3.25M | +27.2% |
| Q3 FY2023 | Sep 30, 2023 | $3.74M | +55.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.55M | +24.4% |
| Q1 FY2023 | Mar 31, 2023 | $3.70M | +71.2% |
| Q4 FY2022 | Dec 31, 2022 | $2.56M | -5.7% |
| Q3 FY2022 | Sep 30, 2022 | $2.41M | -6.6% |
| Q2 FY2022 | Jun 30, 2022 | $2.85M | +25.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.16M | -21.1% |
| Q4 FY2021 | Dec 31, 2021 | $2.71M | +16.2% |
| Q3 FY2021 | Sep 30, 2021 | $2.58M | +21.5% |
| Q2 FY2021 | Jun 30, 2021 | $2.27M | +43.7% |
| Q1 FY2021 | Mar 31, 2021 | $2.74M | +8.2% |
| Q4 FY2020 | Dec 31, 2020 | $2.33M | -26.2% |
| Q3 FY2020 | Sep 30, 2020 | $2.12M | -31.5% |
| Q2 FY2020 | Jun 30, 2020 | $1.58M | -31.7% |
| Q1 FY2020 | Mar 31, 2020 | $2.53M | +43.0% |
| Q4 FY2019 | Dec 31, 2019 | $3.16M | +96.1% |
| Q3 FY2019 | Sep 30, 2019 | $3.10M | +79.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.31M | +69.0% |
| Q1 FY2019 | Mar 31, 2019 | $1.77M | +79.6% |
| Q4 FY2018 | Dec 31, 2018 | $1.61M | +24.0% |
| Q3 FY2018 | Sep 30, 2018 | $1.72M | +88.2% |
| Q2 FY2018 | Jun 30, 2018 | $1.37M | +59.0% |
| Q1 FY2018 | Mar 31, 2018 | $985.00K | +34.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.30M | +74.5% |
| Q3 FY2017 | Sep 30, 2017 | $916.00K | +92.8% |
| Q2 FY2017 | Jun 30, 2017 | $859.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $734.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $745.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $475.00K | – |
See a number that looks wrong?